59 research outputs found
POSSIBLE HEALTH RISKS IN SUBJECTS WITH DOMINANT PLANT FOOD CONSUMPTION
ABSTRACT In two groups of apparently healthy non-obese non-smoking women aged 20-30 years – 79 vegetarians (39 lacto-ovo-vegetarians /plant food, dairy products, eggs/, 40 semi-vegetarians /as lacto-ovo-vegetarians with addition of white meat and fish consumption/) and 81 non-vegetarians (control group on traditional mixed diet) were analyzed the dietary questionnaires of food-frequency and measured the blood concentrations of vitamins B9, C, ?-carotene, B12, D and concentrations of iron. Young women in both groups had similar values of body mass index, concentrations of vitamin C, vitamin B9 and ?-carotene. In vegetarian vs. non-vegetarian group was found the significantly increased daily intake of fiber, whole grain products, pulses, seeds and nuts. These finding suggest that both nutritional groups had the similar nutritional regimen from view of fruit and vegetables and different from view of other key vegetarian food commodities. Vitamin B12, vitamin D and long-chain n-3 fatty acids are not contained in plant food. Bioavailability of iron from food can be lower in presence of phytic acid (from whole grain products and pulses) and fiber (pulses, seeds, nuts, whole grains). In group of lacto-ovo-vegetarians (narrow range of animal food consumption) vs. non-vegetarian or semi-vegetarian groups were found the significantly reduced concentrations of vitamin B12, vitamin D and iron with a greater incidence of deficient values (49 % vs. 13 and 15 % for vitamin B12, 67 % vs. 46 and 50 % for vitamin D, 44 % vs. 20 and 30 % for iron). Long-chain n-3 fatty acid intake (eicosapentaenoic and docosahexaenoic) in lacto-ovo-vegetarian group was significantly reduced and very low (no fish consumption) in comparison to non-vegetarians and semi-vegetarians. Intake of these acids in semi-vegetarians vs. non-vegetarians was non-significantly increased. The substrate for long-chain n-3 fatty acid biosynthesis – ?-linolenic acid was significantly more consumed in vegetarian groups (mainly from linseeds). The findings suggest that limited consumption of animal food and dominant consumption of plant food can be connected with possible health risks (higher incidence of deficient values of vitamin B12, vitamin D, iron and long-chain n-3 fatty acids)
Inhibitory effect of genistein on the invasive potential of human cervical cancer cells via modulation of matrix metalloproteinase-9 and tissue inhibitiors of matrix metalloproteinase-1 expression
Background: One of the most challenging stumbling blocks for the treatment of cancer is the ability of cancer cells to break the natural barriers and spread from its site of origin to non-adjacent regional and distant sites, accounting for high cancer mortality rates. Gamut experimental and epidemiological data advocate the use of pharmacological or nutritional interventions to inhibit or delay various stage(s) of cancer such as invasion and metastasis. Genistein, a promising chemopreventive agent, has gained considerable attention for its powerful anti-carcinogenic, anti-angiogenic and chemosensitizing activities. Methods: In this study, the cytotoxic potential of genistein on HeLa cells by cell viability assay and the mode of cell death induced by genistein were determined by nuclear morphological examination, DNA laddering assay and cell cycle analysis. Moreover, to establish its inhibitory effect on migration of HeLa cells, scratch wound assay was performed and these results were correlated with the expression of genes involved in invasion and migration (MMP-9 and TIMP-1) by RT-PCR. Results: The exposure of HeLa cells to genistein resulted in significant dose- and time-dependent growth inhibition, which was found to be mediated by apoptosis and cell cycle arrest at G2/M phase. In addition, it induced migration-inhibition in a time-dependent manner by modulating the expression of MMP-9 and TIMP-1. Conclusion: Our results signify that genistein may be an effective anti-neoplastic agent to prevent cancer cell growth and invasion and metastasis. Therefore therapeutic strategies utilizing genistein could be developed to substantially reduce cancer morbidity and mortality. © 2012 Elsevier Ltd
Effects of genistein aglycone in osteoporotic, ovariectomized rats: a comparison with alendronate, raloxifene and oestradiol
Association of plasma homocysteine to insuline resistance and metabolic syndrome components in healthy omnivores and vegetarians
Association of plasma homocysteine to insuline resistance and metabolic syndrome components in healthy omnivores and vegetarians
(Nutr. Cancer, 52(1):066-073)Green tea polyphenols modulate secretion of urokinase plasminogen activator (uPA) and inhibit invasive behavior of breast cancer cells
Improvement in asymmetric dimethylarginine and oxidative stress in patients with limb salvage after autologous mononuclear stem cell application for critical limb ischemia
Abstract Background Asymmetric dimethylarginine (ADMA), an endogenous inhibitor of nitric oxide synthase, acts as an inhibitor of angiogenesis and is associated with an increased risk of cardiovascular mortality. Administration of stem cells may affect endogenous mechanisms that regulate ADMA production and metabolism. The aim of the present study was to analyze ADMA concentration and changes in oxidative stress in patients with advanced critical limb ischemia (CLI) after bone marrow-derived mononuclear cell (BM-MNC) therapy. Methods Fifty patients (age 64 ± 11 years, 44 males, 6 females) with advanced CLI (Rutherford category 5 or 6) not eligible for revascularization were treated by intramuscular (n = 25) or intra-arterial (n = 25) injection of 40 ml BM-MNC concentrate. Patients with limb salvage and improved wound healing after 6 months were considered responders to cell therapy. The concentrations of markers of oxidative stress and angiogenesis were analyzed before, and at 3 and 6 months after BM-MNC delivery. Results At 6-month follow-up, four patients died of reasons unrelated to stem cell therapy. Among the survivors, 80% (37/46) showed limb salvage and improved wound healing. At 6 months follow-up, ADMA concentration significantly decreased in patients with limb salvage (1.74 ± 0.66 to 0.90 ± 0.49 μmol/L, p < 0.001), in parallel with decreased tumor necrosis factor (TNF)-α (2.22 ± 0.16 to 1.94 ± 0.38 pg/ml, p < 0.001), and increased reduced glutathione (6.96 ± 3.1 to 8.67 ± 4.2 μmol/L, p = 0.02), superoxide dismutase activity (168 ± 50 to 218 ± 37 U/L, p = 0.002), and coenzyme Q10 concentration (468 ± 182 to 598 ± 283 μg/L, p = 0.02). The number of delivered BM-MNCs significantly correlated with the decrease in ADMA concentration at 3 months (p = 0.004, r = −0.48) and the decrease in TNF-α concentration at 6 months (p = 0.03, r = −0.44) after cell delivery. ADMA or TNF-α improvement did not correlate with the number of applied CD34+ cells, C-reactive protein concentration, leukocyte count, or the dose of atorvastatin. Conclusions The therapeutic benefit of BM-MNC therapy is associated with reduced ADMA levels and oxidative stress. Regulation of the ADMA-nitric oxide axis and improved antioxidant status may be involved in the beneficial effects of stem cell therapy. Trial registration The study was approved and retrospectively registered by ISRCTN registry, ISRCTN16096154 . Registered on 26 July 2016
- …